Solon tablets 50 mg for ulcer and gastritis (sofalcone)

General information on Japanese Solon tablets 4 mg for ulcer and gastritis (sofalcone)

Package details: 100 tablets

Manufacturer: Taisho Pharmaceutical Co., Ltd., Japan

Active ingredient: sofalcone (chemical formula C27H30O6)

Medical effect: Solon tablets are effective for the treatment of gastric ulcer, gastritis and Helicobacter pylori.

Contraindications and precautions: do not use for pregnant and breastfeeding women.

If an allergic reaction occurs, stop taking the medicine and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.

Dosage and administration of Solon tablets 50 mg from Japan for ulcer and gastritis (sofalcone)

For adults: take 2 tablets (100 mg of active ingredient) at a time, 3 times a day. The consulting doctor may adjust the dosage according to age and symptoms.

How effective are Solon tablets 50 mg from Japan for ulcer and gastritis (sofalcone)?

Solon tablets contain sofalcone, a synthetic analog of sophoradin, a polyphenolic compound found in a herb called Sophora tonkinensis. It works by increasing blood flow in gastric wall mucosa, thus, helping recovery of gastric mucosa. Solon tablets are effective for improving gastric mucosal lesion in acute exacerbation phase of acute or chronic gastritis and for the treatment of gastric ulcer.

Who should take Solon tablets 50 mg from Japan?

Solon tablets are recommended for patients with gastrit ulcer or gastritis caused by Helicobacter pylori. Sofalcone reduces the adhesion of this organism to gastric epithelial cells. Solon tablets inhibit growth of Helicobacter pylori, decrease production of vacuolating toxin and induction of interleukin-8 secretion by H. pylori. Studies showed that adding sofalcone to other antibacterial agents increase cure rate up to 94% (H. Isomoto, H. Furusu et al. “Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin”. World Journal of Gastroenterology, 2005, March, 11(11): 1629–1633).